Pharmacological Abortion in a Pandemic: An Italian Medico-Legal Perspective

International Journal of Environmental Research and Public Health

Alessandro Feola¹  Giulio Di Mizio²  Clara Cestonaro³  Anna Aprile³  Matteo Bolcato³  Daniele Rodriguez³ 

[1]Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, Via Luciano Armanni 5, 80138 Naples, Italy

[2]Forensic Medicine, Department of Law, “Magna Graecia” University of Catanzaro, 88100 Catanzaro, Italy

[3]Legal Medicine, University of Padua, 35121 Padua, Italy

关键词: abortion;    RU486;    mifepristone;    pandemic;    COVID-19;    legal medicine;   

DOI  :  10.3390/ijerph182212043

来源: DOAJ

【 摘 要 】

The limitations caused by the spread of the SARS-CoV2 virus have had repercussions on the voluntary termination of pregnancy. During the pandemic, Italy issued updated guidelines regarding voluntary termination of pregnancy by means of mifepristone and prostaglandin. This included news concerning the time limit and location in which this procedure could be accessed: updates partially recognize women’s needs, and they are into line with the European parliament’s recent exhortations. However, these updates do not change the previously provided responsibilities that lie with doctors. This article aimed to compare regulations concerning medical abortion in Italy and other countries, with a focus on recent Italian updates in the context of pandemic.

【 授权许可】

Unknown